Q4 2023 Rani Therapeutics Holdings Inc Earnings Call Transcript
Welcome to the Rani therapeutics, both fourth quarter and full year 2023 financial results and corporate update conference call. At this time, all participants are in a listen only mode. (Operator Instructions)
As a reminder, this call is being recorded today, Wednesday, March 20, 2024. I would now like to turn the conference call over to Keith Patel at Gilmartin Group. Please go ahead.
Thank you, operator. Joining us on the call today from Rani Therapeutics, are Chief Executive Officer Talat Imran; VP of Clinical Development, Arvinder Dhalla; and Chief Financial Officer, Svai Sanford.
During this conference call, management will make forward-looking statements that are subject to risks, uncertainties and assumptions such as but not limited to, those discussed in the Risk Factors section and the company's filings with the Securities and Exchange Commission, including its annual report on Form 10-K and quarterly reports on Form 10-Q, which identify the specific factors that may cause actual results or
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
